ã¨ãã©åºè¡ç±ï¼ã¨ãã©ã¦ã¤ã«ã¹ç ï¼ãæ£ããæããããã«ââï¼ï¼ï¼ææ°ã®è«æãç´¹ä»ããã
æ¬å½ã¯æ²»çè¬ç¹éã¨ãã¾ã¨ãã¨ããããã¨æã£ã¦ãèªåã®è«æ*1æ¸ãã¦ãåéã«ããããè«æèªãã§ããã§ããã©ããã¡ãã¡ã§ã¾ã¨ãã¨ã解説ã¨ããããã§ã©ã¼ããã£ããªã¼ããã®ããã£ããè¿«åã®ããè«æãåºãã®ã§ãã¡ããç´¹ä»ãããã¨ã«ãã¾ããScienceãããèè ã®ãã¡5人ãã¨ãã©ã§äº¡ããªã£ã¦ããã¨ãããã¨ã§追悼記事ãåºã¦ãã¾ãã
è«ææ¬ä½ã¯ãã¡ãã
Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak
ã¿ã¤ãã«ã翻訳ããã¨ããµã¼ãã¤ã©ã³ã¹ã«ãã£ã¦æããã«ãªã£ãã2014å¹´ã«ã¢ã¦ããã¬ã¤ã¯ãèµ·ãããã¨ãã©ã¦ã¤ã«ã¹ã®èµ·æºã¨ä¼æã
2014å¹´3æã«ã·ã¨ã©ã¬ãªãæ¿åºç é¢ããã¼ãã¼ã大å¦ãããã¼ãç 究æãã±ããã¨ããé½å¸ã§ç«ã¡ä¸ããã¨ãã©ã®ãµã¼ãã¤ã©ã³ã¹ãããããªã5æã«æ¬ç©ã®ã¨ãã©æ£è ãè¦ã¤ãã¦ãã¾ã£ãã¨ããããè«æã¯å§ã¾ãã¾ãããã®å¾ã®ã·ã¨ã©ã¬ãªãã®æ··ä¹±ã¯ãåç¥ã®éãã§ãããèè éã¯ã5人ã®ç ç²è ãåºããªãããåå°ã§ãµã³ãã«ï¼æ£è è¡æ¸ ï¼ãåéããã·ã¨ã©ã¬ãªãã®ã©ãã§RNAãæ½åºãã¢ã¡ãªã«ã«éã£ã¦è§£æãè¡ãã¾ãã
éãããµã³ãã«ã¯æ£è 78人ããå ¨é¨ã§99ãåãæ£è ããæ¡è¡ãããã®ãå«ã¿ã¾ãããããå ¨é¨ã·ã¼ã¯ã¨ã³ã¹ãã¦ãããããã®ãµã³ãã«ä¸ã«ããã¨ãã©ã¦ã¤ã«ã¹ã®ï¼ã»ã¼ï¼å ¨é·RNAé åã決å®ãã¾ãããã¨ãã©ã¦ã¤ã«ã¹ã¯ãã¤ãã¹éRNAãéºä¼åã«æã£ã¦ãã¦ãã ããã1ä¸9åå¡©åºãããã®é·ããªã®ã§ãææ°ã®ã·ã¼ã¯ã¨ã³ãµã¼ã«ãããã°ãè¶ã®åããããã§ããæåã®15ãµã³ãã«ã使ã£ã¦æ¡ä»¶ã決ãã¦ãæ®ãã®84ãµã³ãã«ã¯ä¸æ°ã«è§£æãã¾ããã使ã£ãã®ã¯Illumina社ã®HiSeq2500ã1åå以ä¸ããææ°ãã·ã³ã§ãã
é å解æå¾ã®éºä¼å系統解æãã¹ãã¼ãã§ãå°ãåã®è«æã§ãããããã¦ããä¸å¤®ã¢ããªã«ã®ã¨ãã©ã¦ã¤ã«ã¹ã¨ã®é¢ä¿ããã£ãã解決ãä»ååºç¾ããã¦ã¤ã«ã¹ã¯ä¸å¤®ã¢ããªã«ããæ¥ããã®ããã®ãã¢ãéãã¦ã·ã¨ã©ã¬ãªãã«ãã£ã¦ããä¸é£ã®ãã®ã§ããã¨ãããã¨ãåããã¾ãããFig 2ã¨3ã®ç³»çµ±æ¨¹ãè¦ãã¨ãã®ãã¢ã§æ¡ããã¦ã¤ã«ã¹ããã·ã¨ã©ã¬ãªãã®ã¦ã¤ã«ã¹ãåããã¦ãã£ã¦ããã®ãè¯ãåããã¾ããã
ããã«ç´°ããè¦ã¦ã¿ãã¨ãã·ã¨ã©ã¬ãªãã®ã¦ã¤ã«ã¹ã«ã¯åæã®æ®µéãã2種é¡ã®ã¦ã¤ã«ã¹ãåå¨ãã¦ãããã¨ãåããã¾ããããã¯2種é¡ã®ã¦ã¤ã«ã¹ããåæã«ã®ãã¢ããï¼æææ¡å¤§ã®ãã£ããã¨ãªã£ãã¨è¨ããã¦ããã¨ãã©æ£è ã®è¬å¼ãä»ãã¦ï¼ã·ã¨ã©ã¬ãªãã«ä¾µå ¥ãã¦ãã¦ã人ã ã®éã§åºãã£ãã¨èããã¨è¾»è¤ãåãã¾ããã¾ããã·ã¨ã©ã¬ãªãå ã§ã®ä¼æãä¸æ§ã«æ±ãã西ã¸ã¨èµ·ãã¦ãããã¨ãåããã¾ããã10218çªç®ã®éºä¼åå¤ç°ãæã¤ã¦ã¤ã«ã¹ã¯ã·ã¨ã©ã¬ãªãå ã§åºç¾ããå¤ç°ã¯æéãçµã¦ã西ã¸ç§»åããã«å¾ã£ã¦å®å®ãã¦ãããã¨ãããã¦ã¤ã«ã¹ã®ä¼æã示ãæé©ãªææ¨ã¨ãªã£ã¦ãã¾ãã
ã¦ã¤ã«ã¹ã®å¤ç°ã¹ãã¼ããè¦ã¦ã¿ãã¨ãä»åã®ã¨ãã©ã¦ã¤ã«ã¹ã¯ã¨ã¦ãéãéºä¼åå¤ç°ãèµ·ããã¦ãã¾ãããã®äºå®ããä½ãçµè«ãå°ãããã«ã¯ãããªãå®é¨ãå¿ è¦ã§ãããã¢ã¦ããã¬ã¤ã¯ãåæããªããã°ãï¼çµæã¨ãã¦ä½ãèµ·ãããã¯åãããªããã®ã®ï¼ãã人éã«é©å¿ããã¨ãã©ã¦ã¤ã«ã¹ãåºç¾ããå¯è½æ§ãããã¨ãçè éã¯è¿°ã¹ã¦ãã¾ãã
ãã¦ãã¾ãæ°ã«ãªãã®ã¯ä»åè¦ã¤ãã£ãéºä¼åå¤ç°ã«ãã£ã¦ãå®æ¦æå ¥ããã¦ããZMappã®å¹ãã«å¤åãããã®ããªãã®ããã¨ãããã¨ã§ãããï¼ã§ã¯æ¬¡ã®Natureããåºãã°ããã®è«æãã©ããã
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
ã¿ã¤ãã«ã¯ãZMappã«ãããã¨ãã©ã¦ã¤ã«ã¹ç
ãé²è¡ããéé·é¡ã®å復ã
Figure 3ã«ä»ã¾ã§ãµã«ã¢ãã«ã§ä½¿ããã¦ããã¨ãã©ã¦ã¤ã«ã¹Kikwitæ ªã¨ä»åã®ã¢ã¦ããã¬ã¤ã¯ã§æ¡ããGuineaæ ªã®æ¯è¼ãããã¾ãã赤ç¢å°ã§ç¤ºããã¦ããZMappã®ã¨ããã¼ãã¯Guineaæ ªã§ãå¤ç°ãã¦ããªãã§ãããè¿åã«2ã¤ã¢ããé ¸å¤ç°ãããã¾ãããZMappã®çµåãä¸åæ´»æ§ã«ã¯å½±é¿ãã¦ããªããã¨ã
ããã§ã¯å ã»ã©ã®Scienceè«æã«æ»ããã·ã¨ã©ã¬ãªãã®æ ªãè¦ã¦ã¿ã¾ããããããµããªã®Table S4ã§ããZMappã¨ããã¼ãè¿åã«ã¯ãGuineaæ ªã§ãè¦ããã503çªç®ã®ã¢ã©ãã³ããããªã³ã¸ã®ç½®æ以å¤ã«ã¯ã¢ããé ¸å¤ç°ã¯è¦ããã¾ãããã¦ãã¨ã¯ãZMappã®å¹ãç®ãæãªããããªå¤ç°ã¯ä»ã®ã¨ããè¦ã¤ãã£ã¦ããªããä¸å®å¿ã§ããã
åãæ¥ãã1æéãããã§è«æèªãã§ã1æéãããã§æ¸ãã¦ã¿ã¾ãããæ·±ã話ã¯ã¾ãã®æ©ä¼ãããã°ã£ã¦ãã¨ã§ã
*1:ã¨ãã©ãããªãã§ãã¼